TOP TIERMARKET NEWSWIRE
News & sentiment

CHEMOMAB THERAPEUTIC ADR (CMMB) — News & AI sentiment

CHEMOMAB THERAPEUTIC ADR (CMMB) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 42/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $7K — net selling of $7K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 42/100
Insider net (90d)
$7K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

CMMB news in the last 24 hours, 7 days, 30 days and 90 days

How much CMMB coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCMMB storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days542/100CMMB headlines →
Last 90 days1049.3/100CMMB headlines →

Latest stories on CMMB

Aug 31
Aug 31
Chemomab Therapeutics reports Q2 results
Seeking Alpha42 · neutralearnings
Aug 19
Aug 19
Aug 19
Jul 9
Jul 8
Chemomab to merge with Scipher Medicine
Seeking Alpha55 · neutralm&a
Jul 8
Jul 8
Jul 8
Jun 2
Open CMMB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →